BNTX | tickerfilter.com

Fundamental analysis

15%

Profitability 17%

Dept financing 4%

Liquidity 75%

Performance 0%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.03%

1 Month

1.71%

3 Months

-10.66%

6 Months

-3.51%

1 Year

-29.47%

2 Year

-40.02%

Key data

Stock price

$88.25

P/E Ratio

-40.47

DAY RANGE

N/A - N/A

EPS

-$2.15

52 WEEK RANGE

$76.53 - $122.95

52 WEEK CHANGE

-$0.28

MARKET CAP

20.976 B

YIELD

N/A

SHARES OUTSTANDING

237.766 M

DIVIDEND

$2.1322

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/04/2024

BETA

0.65

PUBLIC FLOAT

AVERAGE 10 VOLUME

$450,426

AVERAGE 30 VOLUME

$721,736

Company detail

CEO: Ugur Sahin
Region: US
Website: https://biontech.de/
Employees: 2,955
IPO year: -

Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases. over 400 dedicated, passionate pioneers achieve sensational success and promising breakthroughs time and again by forging new paths – and ensure people all around the world have hope for the future. you too can become a pioneer! http://biontech.de/ http://biontech.de/imprint/

BNTX - BioNTech SE - ADR